OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
AI Today Summary
Miles Wang, an OpenAI researcher known for his work in AI-driven scientific discovery, is leaving OpenAI to start a new company focused on AI models for drug discovery. He is reportedly in talks to raise $200 million at a $2 billion valuation, with Lightspeed potentially leading the funding round, although details remain unconfirmed. The startup aims to leverage AI to find new uses for existing drugs, potentially accelerating drug development timelines.
Covered by 1 source
AI Today publishes original summaries and links out — never the full source article.